First patient-derived cells to study leptomeningeal disease by Staff March 8, 2022 March 8, 2022 0 views 0A team of researchers has been able to add an important resource to study leptomeningeal disease by successfully growing and culturing circulating tumor cells derived from the cerebrospinal fluid of patients with melanoma leptomeningeal disease.Source: sciencedaily.com ScienceDaily 0 FacebookTwitterPinterestEmail previous post Dementia patients struggle to cope with change because of damage to general intelligence brain networks next post How to Turn Off Password-on-Wake in Windows 11 Related Posts Advancing toward a preventative HIV vaccine July 2, 2024 Advancing toward a preventative HIV vaccine July 2, 2024 Genetic study points to oxytocin as possible treatment... July 2, 2024 A new breakthrough in understanding regeneration in a... July 2, 2024 Systematic biases at play in clinical trials July 2, 2024 Crucial gaps in climate risk assessment methods July 2, 2024